Induction of cyclooxygenase-2 in ras-transformed human mammary epithelial cells undergoing apoptosis

Annals of the New York Academy of Sciences

Volumn 973, Issue , 2002, Pages 153-160

  Na, Hye Kyung ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Celecoxib; Cyclooxygenase 2 (COX 2); ET 18 O CH3; Human breast epithelial cells; ras transformed cells

Indexed keywords

ANTINEOPLASTIC AGENT; CELECOXIB; CYCLOOXYGENASE 2; RAS PROTEIN;

APOPTOSIS; BREAST EPITHELIUM; CELL DEATH; CELL TRANSFORMATION; CONFERENCE PAPER; HUMAN; NONHUMAN; PROTEIN INDUCTION; UPREGULATION;

EID: 0036959459     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04626.x     Document Type: Conference Paper

References (35)

1. BENNETT, A. 1986. The production of prostanoids in human cancer: their implications for tumor progression. Prog. Lipid Res. 25: 539-542.
2. MARNETT, L.J. 1992. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52: 5575-5589.
3. LEE, S.H., E. SOYOOLA, P. CHANMUGAM, et al. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267: 25934-25938.
4. KUJUBU, D.A., B.S. FLETCHER, B.C. VARNUM, et al. 1991. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266: 12866-12872.
5. DUBOIS, R.N., J. AWAD, J. MORROW, et al. 1994. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J. Clin. Invest. 93: 493-498.
6. SUBBARAMAIAH, K., N. TELANG, J.T. RAMONETTI, et al. 1996. Transcription of cyclo-oxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 56: 4424-4429.
7. YIP-SCHNEIDER, M.T., D.S. BARNARD, S.D. BILLINGS, et al. 2000. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 21: 139-146.
8. VAN REES, B.P., K. SAUKKONEN, A. RISTIMAKI, et al. 2002. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196: 171-179.
9. CHAN, G., J.O. BOYLE, E.K. YANG, et al. 1999. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59: 991-994.
10. LIN, M.T., R.C. LEE, et al. 2001. Cyclooxygenase-2 inducing Mc1-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells: involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 276: 48997-49002.
11. ISHIKO, O., T. SUMI, H. YHIDA, et al. 2001. Association between overexpression of cyclooxygenase-2 and suppression of apoptosis in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion. Oncol. Rep. 8: 1259-1263.
12. MOHAMMED, S.I., D.W. KNAPP, D.G. BOSTWICK, et al. 1999. Expression of cyclo-oxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res. 59: 5647-5650.
13. CIANCHI, F., C. CORTESINI, P. BECHI, et al. 2001. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121: 1339-1347.
14. LIU, C.H., S.H. CHANG, et al. 2001. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem. 276: 18563-18569.
15. OSHIMA, M., J.E. DINCHUK, S.L. KARGMAN, et al. 1996. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809.
16. GIARDIELLO, F.M., S.R. HAMILTON, A.J. KRUSH, et al. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328: 1313-1316.
17. STEINBACH, G., P.M. LYNCH, R.K. PHILLIPS, et al. 2000. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342: 1946-1952.
18. TSUJII, M. & R.N. DUBOIS. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501.
19. HSU, A.L., T.T. CHING, D.S. WANG, et al. 2000. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem. 275: 11397-11403.
20. CHANG, H.C. & C.F. WENG. 2001. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Oncol. Rep. 8: 1321-1325.
21. FOSSLIEN, E. 2000. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit. Rev. Clin. Lab. Sci. 37: 431-502.
22. SHENG, H., J. SHAO, D.A. DIXON, et al. 2000. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275: 6628-6635.
23. SHENG, H., C.S. WILLIAMS, J. SHAO, et al. 1998. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem. 273: 22120-22127.
24. VAN PUTTEN, V., Z. REFAAT, C. DESSEV, et al. 2001. Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J. Biol. Chem. 276: 1226-1232.
25. JAMES, G.L., M.S. BROWN, M.H. COBB & J.L. GOLDSTEIN. 1994. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells. J. Biol. Chem. 269: 27705-27714.
26. 2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem. 273: 28670-28676.
27. SLICE, L.W., L. BUI, C. MAK & J.H. WALSH. 2000. Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases. Biochem. Biophys. Res. Commun. 276: 406-410.
28. TAYLOR, M.T., K.R. LAWSON, N.A. IGNATENKO, et al. 2000. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells. Cancer Res. 60: 6607-6610.
29. SLATON, J.W., J.A. HAMPTON & S.H. SELMAN. 1994. Exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinoma. J. Urol. 152: 1594-1598.
30. BERKOVIC, D. 1998. Cytotoxic etherphospholipid analogues. Gen. Pharmacol. 31: 511-517.
31. 3, in vitro. Clin. Exp. Metastasis 9: 579-591.
32. WINKLER, J.D., T. ERIS, C.M. SUNG, et al. 1996. Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cells. J. Pharmacol. Exp. Ther. 279: 956-966.
33. BOUCROT, P., J.AUBRY & A. MEZAZIGH. 1995. Severe modifications of ether-ester- or diester-linked glycerolipid and nonglycerolipid synthesis in human neuroblastoma LAN-1 cells cultured with octadecylmethyl-glycerophosphocholine. Arch. Physiol. Biochem. 103: 165-174.
34. SANO, A., X. ZHU, H. SANO, et al. 2001. Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA(2). Am. J. Physiol. Lung Cell Mol. Physiol. 281: L844-L851.
35. BERGGREN, M.I., A. GALLEGOS, L.A. DRESSLER, et al. 1993. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res. 53: 4297-4302.